Michigan Diagnostics is one of the world’s leading manufacturers of diagnostic reagents and kits for research and clinical applications. We are committed to applying the highest quality and innovative solutions to service our clients’ needs. As we have grown we have expanded our operations into multiple operations which are located across the world. Those operations include but are not limited to the manufacturing of Diagnostic and research reagents, Diagnostic kits, rapid tests, clinical labs, medical facilities and cancer research.
We were founded in 1998 by Dr. Brij P. Giri with a single product line of modified cyclodextrins. By the end of 1998, we had filed our first set of patents and had begun manufacturing our highly sensitive chemiluminescent reagents for diagnostic and clinical uses. In 2008 we expanded our production to include biochemistry kits, CLIA kits, and Rapid test kits. We also created strategic partnerships with local and international companies to help develop and manufacture our diagnostic kits. All of our products do have some type of regulatory approval, these either come from the USA FDA, Chinese FDA or CE marked.